Lundbeck Depression Drug To Return To India Market With Warning Label
This article was originally published in PharmAsia News
Executive Summary
India's health ministry is allowing Lundbeck's Deanxit (flupenthixol/malitracen) depression drug to return to the market where it is to be sold by Mankind Pharma, ending a year-long suspension.